Practice vs ambulatory blood pressure measurement under treatment with ramipril (PLUR Study): A randomised, prospective long-term study to evaluate the benefits of ABPM in patients on antihypertensive treatment

Journal of Human Hypertension

Volumn 14, Issue 7, 2000, Pages 435-440

  Schrader, Joachim ^a   Luders S ^a   Zuchner C ^a   Herbold, M ^a   Schrandt, G ^a  

^a ST JOSEFS HOSPITAL   (Germany)

Author keywords

Ambulatory blood pressure monitoring; Office blood pressure; PLUR; Ramipril; Reverse white coat hypertension

Indexed keywords

FELODIPINE; HYDROCHLOROTHIAZIDE; METOPROLOL; NIFEDIPINE; RAMIPRIL;

AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING; WHITE COAT HYPERTENSION;

EID: 0343627971     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001052     Document Type: Article

References (20)

1. Pickering TG, Devereux RB. Ambulatory monotoring of blood pressure as a predictor of cardiovascular risk. Am Heart J 1987; 114: 925-928.
2. Verdecchia P et al. Ambulatory blood pressure - an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
3. Pickering TG et al. How common is white coat hypertension? JAMA 1988; 259: 225-228.
4. Staessen JA et al. For the ambulatory blood pressure monitoring and treatment of hypertension investigators. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. JAMA 1997; 278: 1065-1072.
5. Schrader J, Schoel G. Benefits of noninvasive ambulatory blood pressure monitoring during antihypertensive therapy. J Ambulat Monitoring 1990; 3: 203-214.
6. Schrader J et al. Comparison of the antihypertensive efficiency of nitrendipine, metroprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring. Am J Cardiol 1990; 66: 967-972.
7. Devereux RB et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly stress. Circulation 1983; 68: 470-476.
8. Verdecchia P et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536.
9. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249: 2792-2798.
10. Doutheil A et al. Häufigkeit und Bedeutung einer nächtlichen Hypertonie bei Patienten nach cerebralen Insulten. Nieren-und Hochdruckkrankheiten 1992; 21: 492-494.
11. Benhamou PY et al. Early disturbances of ambulatory blood pressure load in normotensive type I diabetic patient with microalbumin-uria. Diabetes-Care 1992; 15/11: 1614-1619.
12. Clement DL, De Buyzere M, Duprez D. Prognostic value of ambulatory blood pressure monitoring. J Hypertens 1994; 12: 857-864.
13. Redon J et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998, 31: 712-718.
14. The 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990; 24: 606-609.
15. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy Of the Space Labs 90207 determined by the British Hypertension Society Protocol. J Hypertens 1991; 9: 573-574.
16. Blood Pressure Measurement Sectio of the Deutsche Liga zur Bekämpfung des hohen Blutdrucks e. V. (German Hypertension League). Statement on ambulatory blood pressure monitoring by the German Hypertension League. J Hum Hypertens 1995; 9: 777-779.
17. Cavallini MC et al. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995; 26: 413-419.
18. Witte M et al. Entwicklung einer manifesten Hypertonie bei Patienten mit Praxishypertonie. Nieren-und Hochdruckkrankheiten 1996; 25: 214-216.
19. Bidlingmeyer I et al. Isolated office hypertension: A prehypertensive state? J Hypertens 1996; 14: 327-332.
20. Middeke M. Ist die Praxishypertonie die frühste Manifestation der Hochdruckkrankheit? Nieren-und Hochdruckkrankheiten 1994; 8: 386.